| Shariq Ali, MD | |
|
2 Industrial Rd Ste 3-a, Alpha, NJ 08865-4086 | |
| (908) 941-0600 | |
| (484) 786-5214 |
| Full Name | Shariq Ali |
|---|---|
| Gender | Male |
| Speciality | Physical Medicine And Rehabilitation |
| Experience | 23 Years |
| Location | 2 Industrial Rd Ste 3-a, Alpha, New Jersey |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1891783841 | NPI | - | NPPES |
| 0076341 | Medicaid | NJ |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208100000X | Physical Medicine & Rehabilitation | 25MA07920200 (New Jersey) | Primary |
| Entity Name | Alfa Rehabilitation Center Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144761180 PECOS PAC ID: 7416234257 Enrollment ID: O20170504001963 |
News Archive
Triple-negative breast cancer is as bad as it sounds. The cells that form these tumors lack three proteins that would make the cancer respond to powerful, customized treatments. Instead, doctors are left with treating these patients with traditional chemotherapy drugs that only show long-term effectiveness in 20 percent of women with triple-negative breast cancer.
A new study in Health Economics finds that sugary drinks impact behavior and math scores of preschool children.
Despite having the most expensive health care system, the United States ranks last overall compared to six other industrialized countries-Australia, Canada, Germany, the Netherlands, New Zealand, and the United Kingdom-on measures of health system performance in five areas: quality, efficiency, access to care, equity and the ability to lead long, healthy, productive lives, according to a new Commonwealth Fund report.
Onyx Pharmaceuticals, Inc. today announced that the company has begun enrollment in the ASPIRE trial, a Phase 3 international clinical trial evaluating carfilzomib in combination with lenalidomide (Revlimid®) and low dose dexamethasone in patients with relapsed multiple myeloma. The company has an agreement with the U.S. Food and Drug Administration (FDA) on a Special Protocol Assessment (SPA) and received Scientific Advice from the European Medicines Agency (EMA) on the design and planned analysis of the ASPIRE trial.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Shariq Ali, MD 201 Strykers Rd Suite 19 #280, Phillipsburg, NJ 08865-5400 Ph: (908) 941-0600 | Shariq Ali, MD 2 Industrial Rd Ste 3-a, Alpha, NJ 08865-4086 Ph: (908) 941-0600 |
News Archive
Triple-negative breast cancer is as bad as it sounds. The cells that form these tumors lack three proteins that would make the cancer respond to powerful, customized treatments. Instead, doctors are left with treating these patients with traditional chemotherapy drugs that only show long-term effectiveness in 20 percent of women with triple-negative breast cancer.
A new study in Health Economics finds that sugary drinks impact behavior and math scores of preschool children.
Despite having the most expensive health care system, the United States ranks last overall compared to six other industrialized countries-Australia, Canada, Germany, the Netherlands, New Zealand, and the United Kingdom-on measures of health system performance in five areas: quality, efficiency, access to care, equity and the ability to lead long, healthy, productive lives, according to a new Commonwealth Fund report.
Onyx Pharmaceuticals, Inc. today announced that the company has begun enrollment in the ASPIRE trial, a Phase 3 international clinical trial evaluating carfilzomib in combination with lenalidomide (Revlimid®) and low dose dexamethasone in patients with relapsed multiple myeloma. The company has an agreement with the U.S. Food and Drug Administration (FDA) on a Special Protocol Assessment (SPA) and received Scientific Advice from the European Medicines Agency (EMA) on the design and planned analysis of the ASPIRE trial.
› Verified 4 days ago